BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 27072207)

  • 1. Apparent diffusion coefficient value measurements with diffusion magnetic resonance imaging correlated with the expression levels of estrogen and progesterone receptor in breast cancer: A meta-analysis.
    Meng L; Ma P
    J Cancer Res Ther; 2016; 12(1):36-42. PubMed ID: 27072207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Value of apparent diffusion coefficient (ADC) in assessing radiotherapy and chemotherapy success in cervical cancer.
    Fu ZZ; Peng Y; Cao LY; Chen YS; Li K; Fu BH
    Magn Reson Imaging; 2015 Jun; 33(5):516-24. PubMed ID: 25660642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diffusion-weighted imaging (DWI) with apparent diffusion coefficient (ADC) mapping as a quantitative imaging biomarker for prediction of immunohistochemical receptor status, proliferation rate, and molecular subtypes of breast cancer.
    Horvat JV; Bernard-Davila B; Helbich TH; Zhang M; Morris EA; Thakur SB; Ochoa-Albiztegui RE; Leithner D; Marino MA; Baltzer PA; Clauser P; Kapetas P; Bago-Horvath Z; Pinker K
    J Magn Reson Imaging; 2019 Sep; 50(3):836-846. PubMed ID: 30811717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic significance of apparent diffusion coefficient values with diffusion weighted MRI in breast cancer: a meta- analysis.
    Sun JH; Jiang L; Guo F; Zhang XS
    Asian Pac J Cancer Prev; 2014; 15(19):8271-7. PubMed ID: 25339017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can Diffusion-Weighted Imaging and Related Apparent Diffusion Coefficient be a Prognostic Value in Women With Breast Cancer?
    Rabasco P; Caivano R; Simeon V; Dinardo G; Lotumolo A; Gioioso M; Villonio A; Iannelli G; D'Antuono F; Zandolino A; Macarini L; Guglielmi G; Cammarota A
    Cancer Invest; 2017 Feb; 35(2):92-99. PubMed ID: 28107084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apparent diffusion coefficient value of diffusion-weighted imaging for differential diagnosis of ductal carcinoma in situ and infiltrating ductal carcinoma.
    Ding JR; Wang DN; Pan JL
    J Cancer Res Ther; 2016; 12(2):744-50. PubMed ID: 27461644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative apparent diffusion coefficient measurement obtained by 3.0Tesla MRI as a potential noninvasive marker of tumor aggressiveness in breast cancer.
    Durando M; Gennaro L; Cho GY; Giri DD; Gnanasigamani MM; Patil S; Sutton EJ; Deasy JO; Morris EA; Thakur SB
    Eur J Radiol; 2016 Sep; 85(9):1651-8. PubMed ID: 27501902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic value of lymph node metastasis by diffusion-weighted magnetic resonance imaging in cervical cancer.
    He XQ; Wei LN
    J Cancer Res Ther; 2016; 12(1):77-83. PubMed ID: 27072215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rim sign and histogram analysis of apparent diffusion coefficient values on diffusion-weighted MRI in triple-negative breast cancer: Comparison with ER-positive subtype.
    Choi Y; Kim SH; Youn IK; Kang BJ; Park WC; Lee A
    PLoS One; 2017; 12(5):e0177903. PubMed ID: 28542297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diffusion-weighted imaging of breast cancer: correlation of the apparent diffusion coefficient value with prognostic factors.
    Kim SH; Cha ES; Kim HS; Kang BJ; Choi JJ; Jung JH; Park YG; Suh YJ
    J Magn Reson Imaging; 2009 Sep; 30(3):615-20. PubMed ID: 19711411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of the apparent diffusion coefficiency values on diffusion-weighted imaging with prognostic factors for breast cancer.
    Choi SY; Chang YW; Park HJ; Kim HJ; Hong SS; Seo DY
    Br J Radiol; 2012 Aug; 85(1016):e474-9. PubMed ID: 22128125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Correlations between apparent diffusion coefficient in diffusion?weighted magnetic resonance imaging and molecular subtypes of invasive breast cancer masses].
    Shang LT; Yang JF; Lu J; Wang TT; Zhou Y; Xing XB; Wang XK; Yang SH; Hu MY
    Nan Fang Yi Ke Da Xue Xue Bao; 2017 Oct; 37(10):1410-1414. PubMed ID: 29070476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trial.
    Pentheroudakis G; Kalogeras KT; Wirtz RM; Grimani I; Zografos G; Gogas H; Stropp U; Pectasides D; Skarlos D; Hennig G; Samantas E; Bafaloukos D; Papakostas P; Kalofonos HP; Pavlidis N; Fountzilas G
    Breast Cancer Res Treat; 2009 Jul; 116(1):131-43. PubMed ID: 18668363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apparent diffusion coefficient in estrogen receptor-positive invasive ductal breast carcinoma: correlations with tumor-stroma ratio.
    Ko ES; Han BK; Kim RB; Cho EY; Ahn S; Nam SJ; Ko EY; Shin JH; Hahn SY
    Radiology; 2014 Apr; 271(1):30-7. PubMed ID: 24475830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic and prognostic value of pretreatment SUV in 18F-FDG/PET in breast cancer: comparison with apparent diffusion coefficient from diffusion-weighted MR imaging.
    Baba S; Isoda T; Maruoka Y; Kitamura Y; Sasaki M; Yoshida T; Honda H
    J Nucl Med; 2014 May; 55(5):736-42. PubMed ID: 24665089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of triple-negative and estrogen receptor-positive/progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters: a potentially useful method for disease characterization.
    Basu S; Chen W; Tchou J; Mavi A; Cermik T; Czerniecki B; Schnall M; Alavi A
    Cancer; 2008 Mar; 112(5):995-1000. PubMed ID: 18098228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diffusion-weighted MRI of estrogen receptor-positive, HER2-negative, node-negative breast cancer: association between intratumoral heterogeneity and recurrence risk.
    Kim JY; Kim JJ; Hwangbo L; Lee JW; Lee NK; Nam KJ; Choo KS; Kang T; Park H; Son Y; Grimm R
    Eur Radiol; 2020 Jan; 30(1):66-76. PubMed ID: 31385051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Relationship between Breast Cancer Subtypes, Prognostic Factors, and Apparent Diffusion Coefficient Histogram Analysis.
    Aktas E; Uylar Seber T; Seber T; Burcek NV; Akay E; Arslan A; Karagöz Eren S; Ozhan N; Yaltırık Bilgin E; Savran B; Akdur P
    Curr Med Imaging; 2024; 20(1):e15734056271069. PubMed ID: 38616751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Added value of mean and entropy of apparent diffusion coefficient values for evaluating histologic phenotypes of invasive ductal breast cancer with MR imaging.
    Suo S; Zhang D; Cheng F; Cao M; Hua J; Lu J; Xu J
    Eur Radiol; 2019 Mar; 29(3):1425-1434. PubMed ID: 30116958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation between 3T apparent diffusion coefficient values and grading of invasive breast carcinoma.
    Cipolla V; Santucci D; Guerrieri D; Drudi FM; Meggiorini ML; de Felice C
    Eur J Radiol; 2014 Dec; 83(12):2144-2150. PubMed ID: 25305145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.